Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health    CVS

CVS HEALTH (CVS)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

CVS Health : Today's Research Reports on Stocks to Watch: CVS Health and Walgreens Boots Alliance

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/19/2017 | 02:05pm CET

NEW YORK, NY / ACCESSWIRE / June 19, 2017 / Even pharmacy chains like CVS Health Corp.'s and Walgreens Boots Alliance's shares were shaky after Amazon announced its deal to acquire Whole Foods. Grocery stores and pharmacy chains were feeling the pressure after Friday's big announcement. Despite the acquisition not directly affecting CVS nor Walgreens, the two stocks saw shares drop as investors cautiously wait to see if there will be any potential threat. It also doesn't help that a CNBC report back in May had indicated that Amazon may also be interesting in launching its own delivery and online pharmacy business.

RDI Initiates Coverage on:

CVS Health Corporation
https://ub.rdinvesting.com/news/?ticker=CVS

Walgreens Boots Alliance, Inc.
https://ub.rdinvesting.com/news/?ticker=WBA

CVS Health Corporation's (NYSE: CVS) shares closed down 3.78% on Friday on trading volume more than twice as large as usual. CVS was among other pharmacy stocks to drop after Amazon announced it was buying Whole Foods. Traders now may have reason to worry that the online retail giant may be choosing pharmaceutical sales as the next thing to break into. CVS also recently reported a 4.7% decrease in same-store sales in its Q1 report which was not that assuring for traders. In other news the company did announce that in partnership with Drug Store News and Mack Elevation, it will hold an innovation summit that brings together leaders from major healthcare, technology and consumer brands including Facebook, Under Armour, Google and IBM. The summit will be for a discussion about emerging trends that are helping reshape the health care industry.

Access RDI's CVS Health Research Report at:
https://ub.rdinvesting.com/news/?ticker=CVS

Walgreens Boots Alliance, Inc.'s shares closed down 4.99% on Friday after the big Amazon news. Plus investors weren't thrilled over some pessimistic updates on its ongoing potential merger with Rite-Aid. The merger has been now in the process for about 1.5 years. A Street.com report indicated that a SEC filing by Rite Aid didn't have an upbeat tone about completing the deal. The Federal Trade Commission is expected to resolve its antitrust review of the merger before July 4th. Chairman Maureen Ohlhausen and Terrell McSweeny are two sitting members that are left who need to vote to challenge the deal before the 7th of next month. If they don't, Walgreens will able to consummate the deal. Traders are eagerly waiting for the FTC's decision.

Access RDI's Walgreens Boots Alliance Research Report at:
https://ub.rdinvesting.com/news/?ticker=WBA

Our Actionable Research on CVS Health Corporation (NYSE: CVS) and Walgreens Boots Alliance, Inc. (NASDAQ: WBA) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Nadia Noorani, CFA® charter holder. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

[email protected]

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com


© Accesswire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH
12/14 CVS HEALTH : chief information officer resigns
12/14 CVS HEALTH : Foundation Announces Grant to Increase Access to Provider Education..
12/14 CVS HEALTH : Solera Health Expands Its Board of Directors with the Addition of H..
12/12 CVS HEALTH : 3 Reasons Why Florida Addiction Recovery Center CEO Is Wary Of $77 ..
12/11 CVS HEALTH : 3 Reasons Why Florida Addiction Recovery Center CEO Is Wary Of $77 ..
12/08 CVS expects U.S. Justice Department to handle review of Aetna deal
12/08 CVS HEALTH : A.M. Best Places Credit Ratings of SilverScript Insurance Company U..
12/08 CVS HEALTH : Greg's Pharmacy, Bluffton, will become a CVS Pharmacy
12/07 MYERS INDUSTRIES : Names Chris DuPaul as Group President, Distribution
12/07 CVS HEALTH : Meningitis B Vaccine Available to Students, Faculty and Staff at UM..
More news
News from SeekingAlpha
12/15 Just Turned 40? How To Reach A Goal Of $1.5 Million.
12/15 MY JOURNEY TO FINANCIAL INDEPENDENCE : 86-Stock November Portfolio Update - Buyi..
12/14 The Next 20 Dividend Achievers Absolutely Trounce The Market
12/14 WALGREENS BOOTS ALLIANCE : Trading At A Bargain
12/13 The Value Of Reliability And Why Omega Healthcare Is A Value Trap
Financials ($)
Sales 2017 184 B
EBIT 2017 9 955 M
Net income 2017 5 255 M
Debt 2017 24 517 M
Yield 2017 2,81%
P/E ratio 2017 14,11
P/E ratio 2018 12,39
EV / Sales 2017 0,52x
EV / Sales 2018 0,49x
Capitalization 71 720 M
Chart CVS HEALTH
Duration : Period :
CVS Health Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Technical analysis trends CVS HEALTH
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 86,1 $
Spread / Average Target 22%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH-9.24%71 720
WALGREENS BOOTS ALLIANCE-13.34%69 681
EXPRESS SCRIPTS HOLDING CO0.33%39 091
MCKESSON CORPORATION10.51%32 772
AMERISOURCEBERGEN CORP.13.16%19 477
CARDINAL HEALTH INC-15.84%19 023